Ligand Portfolio

We believe Ligand has assembled one of the largest portfolio of assets among its biotech peers with 70 fully funded partnered programs.

The portfolio covers a diverse array of indications with many programs in late stages of development.



Pie Chart
Distribution of Therapeutic Areas
Oncology28
CNS8
Inflammation5
Metabolic Disease4
Blood Disorder5
Anti-microbial5
Anti-viral4
Cardiology3
Other8
Distribution of Partners
GSK7
Merck7
Pfizer5
BMS5
AstraZeneca2
Sanofi Aventis2
Eli Lilly4



 

 

Site 'Main' Navigation: